Teladoc Health (TDOC) EV to EBITDA (2015 - 2026)

Teladoc Health has disclosed EV to EBITDA across 12 years of filings, most recently posting 20.65 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 30.81% year-over-year to 20.65; the TTM figure through Jun 2026 stood at 4.1 (down 27.8% YoY), while the FY2025 annual figure was 1.78, down 552.53% from the prior year.
• EV to EBITDA came in at 20.65 for Q2 2026 at Teladoc Health, down from 3.77 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 198.27 in Q1 2022 to a low of 70.35 in Q4 2023.
• Average EV to EBITDA over 5 years is 1.66, with a median of 9.97 recorded in 2024.
• Year-over-year, EV to EBITDA soared 161.41% in 2022 and tumbled 9051.37% in 2023.
• Over 5 years, EV to EBITDA stood at 0.77 in 2022, then sank by 9051.37% to 70.35 in 2023, then surged by 91.81% to 5.76 in 2024, then tumbled by 125.12% to 12.98 in 2025, then tumbled by 59.15% to 20.65 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 20.65 in Q2 2026, 3.77 in Q1 2026, and 12.98 in Q4 2025.